http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#Head
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#assertion
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#provenance
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#pubinfo
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#assertion
http://purl.obolibrary.org/obo/DOID_7166
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_7166
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00741
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
http://www.w3.org/2000/01/rdf-schema#label
hydrocortisone tablets usp are indicated in the following conditions endocrine disorders primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer rheumatic disorders as adjunctive therapy for short term administration to tide the patient over an acute episode or exacerbation in psoriatic arthritis rheumatoid arthritis including juvenile rheumatoid arthritis selected cases may require low dose maintenance therapy ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post traumatic osteoarthritis synovitis of osteoarthritis epicondylitis collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus systemic dermatomyositis polymyositis acute rheumatic carditis dermatologic diseases pemphigus bullous dermatitis herpetiformis severe erythema multiforme stevens johnson syndrome exfoliative dermatitis mycosis fungoides severe psoriasis severe seborrheic dermatitis allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis serum sickness bronchial asthma contact dermatitis atopic dermatitis drug hypersensitivity reactions ophthalmic diseases severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic conjunctivitis keratitis allergic corneal marginal ulcers herpes zoster ophthalmicus iritis and iridocyclitis chorioretinitis anterior segment inflammation diffuse posterior uveitis and choroiditis optic neuritis sympathetic ophthalmia respiratory diseases symptomatic sarcoidosis loeffler s syndrome not manageable by other means berylliosis fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy aspiration pneumonitis hematologic disorders idiopathic thrombocytopenic purpura in adults secondary thrombocytopenia in adults acquired autoimmune hemolytic anemia erythroblastopenia rbc anemia congenital erythroid hypoplastic anemia neoplastic diseases for palliative management of leukemias and lymphomas in adults acute leukemia of childhood edematous states to induce a diuresis or remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus gastrointestinal diseases to tide the patient over a critical period of the disease in ulcerative colitis regional enteritis nervous system acute exacerbations of multiple sclerosis miscellaneous tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy trichinosis with neurologic or myocardial involvement
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00741
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#provenance
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#pubinfo
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#sig
http://purl.org/nanopub/x/hasSignature
ERfI6n0qfdjh1uTjXviyhvUvOlYOjv3BBd4qFpxz6sGdLzS8cDCi7/W+PzAmrLT9Ce7p5z2S/Cz5vRd7eAaa9CrgaPi4lAMfeJ6uYltwDxQcM5iTubEL2zVSO1IWl5K1d27isakP4BuC3CQ50g7yad6zabU3d2GAdBs9kVYMFm4=
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://purl.org/dc/terms/created
2021-06-13T13:07:39.288+02:00
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAAc_am_LWT_TWmhJy8gBXbYVKo4H0vksRbL1UN8vYw0E
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs